Obesity and esophageal cancer: GERD, Barrett´s esophagus, and molecular carcinogenic pathways.
Francisco SchlottmannNicolás H DreifussMarco G PattiPublished in: Expert review of gastroenterology & hepatology (2020)
The risk of esophageal cancer among obese individuals could be partially explained by several factors: high prevalence of GERD; linear association between central adiposity and Barrett´s esophagus development; low levels of adiponectin and high levels of leptin that alter cell proliferation processes; insulin-resistant state that creates a tumorigenesis environment; and changes in the esophageal microbiota due to unhealthy dietary habits that promote carcinogenesis. In addition, a large proportion of obese patients are undergoing sleeve gastrectomy which can worsen GERD or cause de novo reflux, esophagitis, and Barrett´s metaplasia.
Keyphrases
- obese patients
- insulin resistance
- bariatric surgery
- weight loss
- gastroesophageal reflux disease
- metabolic syndrome
- type diabetes
- cell proliferation
- roux en y gastric bypass
- gastric bypass
- adipose tissue
- weight gain
- glycemic control
- high fat diet induced
- skeletal muscle
- signaling pathway
- polycyclic aromatic hydrocarbons
- single molecule